Skip to main content

Table 1 Clinical characteristics for men presenting for evaluation and treatment of adult onset hypogonadism, and men treated chronically with transdermal testosterone

From: SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking?

  Adult onset hypogonadism
(n = 33)
T-treated hypogonadal men
(n = 25)
P value
Age (yrs) 45 (31.5–55.0)a 61.0 (48.0–67.5) .002
BMI (kg/m2) 32.0 (27.8–39.3) 29.1 (24.6–33.1) .04
Testosterone (ng/dL) 317 (237–391) 452 (360–528) .001
SHBG (nmol/L) 25.7 (21.2–35.0) 31.0 (22.5–40.5) .189
Free testosterone (pg/mL) 50.7 (44.5–61.5) 65.3 (45.8–95.0) .084
  1. To convert total testosterone levels to nmol/L multiply by 0.0347
  2. aMedian (25–75%)